D-Amino Acid Oxidase Inhibition: A New Glutamate Twist for Clozapine Augmentation in Schizophrenia?
-
Published:2018-09
Issue:6
Volume:84
Page:396-398
-
ISSN:0006-3223
-
Container-title:Biological Psychiatry
-
language:en
-
Short-container-title:Biological Psychiatry
Subject
Biological Psychiatry
Reference10 articles.
1. Sodium benzoate, a D-amino acid oxidase inhibitor, added to clozapine for the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial;Lin;Biol Psychiatry,2018
2. Add-on treatment of benzoate for schizophrenia: A randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor;Lane;JAMA Psychiatry,2013
3. The neurobiology of D-amino acid oxidase (DAO) and its involvement in schizophrenia;Verrall;Mol Psychiatry,2010
4. Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists;Papouin;Cell,2012
5. D-amino acid oxidase activity and expression are increased in schizophrenia;Burnet;Mol Psychiatry,2008
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献